Stenotrophomonas maltophilia strains isolated from a university hospital in Japan: genomic variability and antibiotic resistance

References

1. Alonso A., Martínez J. L. 1997; Multiple antibiotic resistance in Stenotrophomonas maltophilia. Antimicrob Agents Chemother 41:1140–1142[PubMed]
   [Google Scholar]
2. Araoka H., Baba M., Yoneyama A. 2010; Risk factors for mortality among patients with Stenotrophomonas maltophilia bacteremia in Tokyo, Japan, 1996–2009. Eur J Clin Microbiol Infect Dis 29:605–608 [View Article][PubMed]
   [Google Scholar]
3. Chang L. L., Chen H. F., Chang C. Y., Lee T. M., Wu W. J. 2004; Contribution of integrons, and SmeABC and SmeDEF efflux pumps to multidrug resistance in clinical isolates of Stenotrophomonas maltophilia. J Antimicrob Chemother 53:518–521 [View Article][PubMed]
   [Google Scholar]
4. CLSI 2007; Performance Standards for Antimicrobial Susceptibility Testing; fSeventeenth Informational Supplement. Wayne, PA: Clinical and Laboratory Standards Institute;
5. Coenye T., Vanlaere E., LiPuma J. J., Vandamme P. 2004; Identification of genomic groups in the genus Stenotrophomonas using gyrB RFLP analysis. FEMS Immunol Med Microbiol 40:181–185 [View Article][PubMed]
   [Google Scholar]
6. Crossman L. C., Gould V. C., Dow J. M., Vernikos G. S., Okazaki A., Sebaihia M., Saunders D., Arrowsmith C., Carver T.& other authors ( 2008; The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants. Genome Biol 9:R74 [View Article][PubMed]
   [Google Scholar]
7. Datta N., Hedges R. W. 1972; Host ranges of R factors. J Gen Microbiol 70:453–460 [View Article][PubMed]
   [Google Scholar]
8. Denton M., Kerr K. G. 1998; Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin Microbiol Rev 11:57–80[PubMed]
   [Google Scholar]
9. Garciá de Viedma D., Marín M., Cercenado E., Alonso R., Rodríguez-Créixems M., Bouza E. 1999; Evidence of nosocomial Stenotrophomonas maltophilia cross-infection in a neonatology unit analyzed by three molecular typing methods. Infect Control Hosp Epidemiol 20:816–820 [View Article][PubMed]
   [Google Scholar]
10. Gould V. C., Okazaki A., Avison M. B. 2006; Beta-lactam resistance and beta-lactamase expression in clinical Stenotrophomonas maltophilia isolates having defined phylogenetic relationships. J Antimicrob Chemother 57:199–203 [View Article][PubMed]
    [Google Scholar]
11. Hauben L., Vauterin L., Moore E. R., Hoste B., Swings J. 1999; Genomic diversity of the genus Stenotrophomonas. Int J Syst Bacteriol 49:1749–1760 [View Article][PubMed]
    [Google Scholar]
12. Kaiser S., Biehler K., Jonas D. 2009; A Stenotrophomonas maltophilia multilocus sequence typing scheme for inferring population structure. J Bacteriol 191:2934–2943 [View Article][PubMed]
    [Google Scholar]
13. Lambert T., Ploy M. C., Denis F., Courvalin P. 1999; Characterization of the chromosomal aac(6′)-Iz gene of Stenotrophomonas maltophilia. Antimicrob Agents Chemother 43:2366–2371[PubMed]
    [Google Scholar]
14. Liaw S. J., Teng L. J., Hsueh P. R., Ho S. W., Luh K. T. 2002; In vitro activities of antimicrobial combinations against clinical isolates of Stenotrophomonas maltophilia. J Formos Med Assoc 101:495–501[PubMed]
    [Google Scholar]
15. Liaw S. J., Lee Y. L., Hsueh P. R. 2010; Multidrug resistance in clinical isolates of Stenotrophomonas maltophilia: roles of integrons, efflux pumps, phosphoglucomutase (SpgM), and melanin and biofilm formation. Int J Antimicrob Agents 35:126–130 [View Article][PubMed]
    [Google Scholar]
16. Looney W. J., Narita M., Mühlemann K. 2009; Stenotrophomonas maltophilia: an emerging opportunist human pathogen. Lancet Infect Dis 9:312–323 [View Article][PubMed]
    [Google Scholar]
17. Nicodemo A. C., Paez J. I. 2007; Antimicrobial therapy for Stenotrophomonas maltophilia infections. Eur J Clin Microbiol Infect Dis 26:229–237 [View Article][PubMed]
    [Google Scholar]
18. Okazaki A., Avison M. B. 2007; Aph(3′)-IIc, an aminoglycoside resistance determinant from Stenotrophomonas maltophilia. Antimicrob Agents Chemother 51:359–360 [View Article][PubMed]
    [Google Scholar]
19. Okazaki A., Avison M. B. 2008; Induction of L1 and L2 beta-lactamase production in Stenotrophomonas maltophilia is dependent on an AmpR-type regulator. Antimicrob Agents Chemother 52:1525–1528 [View Article][PubMed]
    [Google Scholar]
20. Ploy M. C., Denis F., Courvalin P., Lambert T. 2000; Molecular characterization of integrons in Acinetobacter baumannii: description of a hybrid class 2 integron. Antimicrob Agents Chemother 44:2684–2688 [View Article][PubMed]
    [Google Scholar]
21. Tan C. K., Liaw S. J., Yu C. J., Teng L. J., Hsueh P. R. 2008; Extensively drug-resistant Stenotrophomonas maltophilia in a tertiary care hospital in Taiwan: microbiologic characteristics, clinical features, and outcomes. Diagn Microbiol Infect Dis 60:205–210 [View Article][PubMed]
    [Google Scholar]
22. Valdezate S., Vindel A., Martín-Dávila P., Del Saz B. S., Baquero F., Cantón R. 2004; High genetic diversity among Stenotrophomonas maltophilia strains despite their originating at a single hospital. J Clin Microbiol 42:693–699 [View Article][PubMed]
    [Google Scholar]